# Stage 13: Approved Roadmap — Findings

Schema: `_core/FINDING-SCHEMA.md`. Draft and confirmed findings are kept in separate sections below — never merge them.

## Draft Findings

(hypotheses / observations not yet confirmed — MUST NOT be cited by other stages)

_None yet._

---

## Confirmed Findings

(meet the evidence standard in `_core/EVIDENCE-STANDARD.md` — safe to cite from later stages)

**None.** Per CONTEXT §Finding discipline, Stage 13 findings are expected to be rare — recorded only where roadmap assembly exposes a genuine inconsistency **between confirmed prior facts**. Assembling the roadmap from the Stage 05/08/10/11/12 confirmed inputs exposed **no such inconsistency**: the value-priority sequence, O1–O9 orderings, W1–W6 windows, cost placements, and end-state dispositions are mutually consistent, and the roadmap honours all of them with zero departures (`outputs/proposed-roadmap.md` §4).

Two placement details were surfaced during assembly but are **not** inconsistencies between confirmed facts — they are points the source documents deliberately leave to sprint planning, classified as **implementation-specifications** (not findings, not human decisions), recorded in `decisions.md` DEC-13-04:

1. **CI schedule seam host** — the register attaches it to the "first Class B control" (`sequencing-economics.md` §3, F-10-02) while the value sequence places the first *scheduled-execution* capability (C6) ahead of the first *Class B eval* capability (C3). Both source claims are internally correct; which item carries the trivial seam is a sprint-planning detail (`outputs/proposed-roadmap.md` Item 3.1).
2. **C10 build trigger** — the end-state map builds C10 "when a write-capable consumer needs it," and no current portfolio item forces it (C12 has bespoke approval; C13 applies via Upload/Enroll). This is an on-demand design intent, not a contradiction (`outputs/proposed-roadmap.md` §3).

---

## Parked / Rejected

_None._

## Next action

**Stage 13 executor pass complete — status `awaiting-critic`.** Run the independent critic per `CRITIC.md` → `outputs/critic-review.md`. On PASS, mark `awaiting-human-decision` and present `outputs/stage-13-approval-prompt.md` to the human reviewer. This stage never closes automatically.
